Cutaneous T cell lymphoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides
Condition: Mycosis Fungoides Intervention: Drug: Brentuximab vedotin Sponsors: M.D. Anderson Cancer Center; Seagen Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2022 Category: Research Source Type: clinical trials
L19IL2/L19TNF in Skin Cancer Patients
Conditions: BCC - Basal Cell Carcinoma; SCC - Squamous Cell Carcinoma; Merkel Cell Carcinoma; Keratoacanthoma of Skin; Malignant Adnexal Tumors of the Skin (MATS); Tumors From Cutaneous T-cell Lymphoma (CTCL); Kaposi Sarcoma Intervention: Drug: L19IL2/L19TNF Sponsor: Philogen S.p.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2022 Category: Research Source Type: clinical trials